{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T12:06:25Z","timestamp":1748433985896,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493970285"},{"type":"electronic","value":"9781493970308"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-1-4939-7030-8_2","type":"book-chapter","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T07:05:27Z","timestamp":1494572727000},"page":"21-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Color Segmentation-Based Method to Quantify Atherosclerotic Lesion Compositions with Immunostaining"],"prefix":"10.1007","author":[{"given":"Congqing","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Daugherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,13]]},"reference":[{"key":"2_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1126\/science.272.5262.685","volume":"272","author":"JL Breslow","year":"1996","unstructured":"Breslow JL (1996) Mouse models of atherosclerosis. Science 272:685\u2013688","journal-title":"Science"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI117179","volume":"93","author":"S Ishibashi","year":"1994","unstructured":"Ishibashi S, Goldstein JL, Brown MS, Herz J, Burns DK (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93:1885\u20131893","journal-title":"J Clin Invest"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","volume":"71","author":"AS Plump","year":"1992","unstructured":"Plump AS, Smith JD, Hayek T, Aaltosetala K, Walsh A, Verstuyft JG et al (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in ES cells. Cell 71:343\u2013353","journal-title":"Cell"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1411543","volume":"258","author":"SH Zhang","year":"1992","unstructured":"Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468\u2013471","journal-title":"Science"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A Daugherty","year":"2000","unstructured":"Daugherty A, Manning MW, Cassis LA (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105:1605\u20131612","journal-title":"J Clin Invest"},{"key":"2_CR6","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1161\/01.CIR.0000150540.54220.C4","volume":"110","author":"A Daugherty","year":"2004","unstructured":"Daugherty A, Rateri DL, Lu H, Inagami T, Cassis LA (2004) Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation 110:3849\u20133857","journal-title":"Circulation"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1161\/01.CIR.0000137970.47771.AF","volume":"110","author":"S Wassmann","year":"2004","unstructured":"Wassmann S, Czech T, van Eickels M, Fleming I, Bohm M, Nickenig G (2004) Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E\/angiotensin II type 1A receptor double-knockout mice. Circulation 110:3062\u20133067","journal-title":"Circulation"},{"key":"2_CR8","first-page":"984","volume":"118","author":"H Lu","year":"2008","unstructured":"Lu H, Rateri DL, Feldman DL, Charnigo RJ Jr, Fukamizu A, Ishida J et al (2008) Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice. J Clin Invest 118:984\u2013993","journal-title":"J Clin Invest"},{"key":"2_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2217\/17460875.3.6.625","volume":"3","author":"A Daugherty","year":"2008","unstructured":"Daugherty A, Lu H, Rateri DL, Cassis LA (2008) Augmentation of the renin-angiotensin system by hypercholesterolemia promotes vascular diseases. Future Lipidol 3:625\u2013636","journal-title":"Future Lipidol"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1111\/j.1476-5381.2011.01712.x","volume":"165","author":"H Lu","year":"2012","unstructured":"Lu H, Balakrishnan A, Howatt DA, Wu C, Charnigo R, Liau G et al (2012) Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis. Br J Pharmacol 165:2000\u20132008","journal-title":"Br J Pharmacol"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1161\/ATVBAHA.113.301777","volume":"33","author":"XC Chen","year":"2013","unstructured":"Chen XC, Lu H, Zhao M, Tashiro K, Cassis LA, Daugherty A (2013) Angiotensin-converting enzyme promotes atherosclerosis through an angiotensin I to angiotensin II pathway involving leukocytes. Arterioscler Thromb Vasc Biol 33:2075\u20132080","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/ATVBAHA.115.306740","volume":"36","author":"H Lu","year":"2016","unstructured":"Lu H, Wu C, Howatt DA, Balakrishnan A, Moorleghen JJ, Chen X et al (2016) Angiotensinogen exerts effects independent of angiotensin II. Arterioscler Thromb Vasc Biol 36:256\u2013265","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1749-6632.1999.tb07789.x","volume":"892","author":"A Daugherty","year":"1999","unstructured":"Daugherty A, Cassis L (1999) Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -\/- mice. Ann N Y Acad Sci 892:108\u2013118","journal-title":"Ann N Y Acad Sci"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/01.CIR.103.3.448","volume":"103","author":"D Weiss","year":"2001","unstructured":"Weiss D, Kools JJ, Taylor WR (2001) Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation 103:448\u2013454","journal-title":"Circulation"},{"key":"2_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1161\/HYPERTENSIONAHA.108.111120","volume":"52","author":"T Imanishi","year":"2008","unstructured":"Imanishi T, Tsujioka H, Ikejima H, Kuroi A, Takarada S, Kitabata H et al (2008) Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes. Hypertension 52:563\u2013572","journal-title":"Hypertension"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342:145\u2013153","journal-title":"N Engl J Med"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"S Yusuf","year":"2008","unstructured":"ONTARGET Investigators, Yusuf S, Teo KK, Pogue J, Dyal L, Copland I et al (2008) Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358:1547\u20131559","journal-title":"N Engl J Med"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-59745-571-8_4","volume":"139","author":"H Lu","year":"2007","unstructured":"Lu H, Rateri DL, Daugherty A (2007) Immunostaining of mouse atherosclerosis lesions. Methods Mol Med 139:77\u201394","journal-title":"Methods Mol Med"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.115.05166","volume":"65","author":"C Wu","year":"2015","unstructured":"Wu C, Xu Y, Lu H, Howatt DA, Balakrishnan A, Moorleghen JJ et al (2015) Cys18-Cys137 disulfide bond in mouse angiotensinogen does not affect AngII-dependent functions in vivo. Hypertension 65:800\u2013805","journal-title":"Hypertension"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/HYPERTENSIONAHA.115.06040","volume":"66","author":"F Yiannikouris","year":"2015","unstructured":"Yiannikouris F, Wang Y, Shoemaker R, Larian N, Thompson J, English VL et al (2015) Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice. Hypertension 66:836\u2013842","journal-title":"Hypertension"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.7156\/v4i4p183","volume":"4","author":"C Wu","year":"2011","unstructured":"Wu C, Lu H, Cassis LA, Daugherty A (2011) Molecular and pathophysiological features of angiotensinogen: a mini review. N Am J Med Sci (Boston) 4:183\u2013190","journal-title":"N Am J Med Sci (Boston)"},{"key":"2_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1681\/ASN.2011121159","volume":"23","author":"T Matsusaka","year":"2012","unstructured":"Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H et al (2012) Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23:1181\u20131189","journal-title":"J Am Soc Nephrol"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/ATVBAHA.115.307038","volume":"36","author":"XC Chen","year":"2016","unstructured":"Chen XC, Howatt DA, Balakrishnan A, Moorleghen JJ, Wu CQ, Cassis LA et al (2016) Angiotensin-converting enzyme in smooth muscle cells promotes atherosclerosis. Arterioscler Thromb Vasc Biol 36:1085\u20131089","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s10571-012-9862-y","volume":"32","author":"J Benicky","year":"2012","unstructured":"Benicky J, Hafko R, Sanchez-Lemus E, Aguilera G, Saavedra JM (2012) Six commercially available angiotensin II AT(1) receptor antibodies are non-specific. Cell Mol Neurobiol 32:1353\u20131365","journal-title":"Cell Mol Neurobiol"},{"key":"2_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00982","volume":"61","author":"M Herrera","year":"2013","unstructured":"Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM (2013) Response to lack of specificity of commercial antibodies leads to misidentification of angiotensin type-1 receptor protein. Hypertension 61:e32","journal-title":"Hypertension"},{"key":"2_CR26","first-page":"115","volume":"37","author":"G Zhang","year":"2015","unstructured":"Zhang G, Chen Y, BilalWaqar A, Han L, Jia M, Xu C et al (2015) Quantitative analysis of rabbit coronary atherosclerosis. Practical techniques utilizing open-source software. Anal Quant Cytol Histol 37:115\u2013122","journal-title":"Anal Quant Cytol Histol"},{"key":"2_CR27","first-page":"4995","volume":"29","author":"T Vrekoussis","year":"2009","unstructured":"Vrekoussis T, Chaniotis V, Navrozoglou I, Dousias V, Pavlakis K, Stathopoulos EN et al (2009) Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model. Anticancer Res 29:4995\u20134998","journal-title":"Anticancer Res"},{"key":"2_CR28","first-page":"293","volume":"209","author":"A Daugherty","year":"2003","unstructured":"Daugherty A, Whitman SC (2003) Quantification of atherosclerosis in mice. Methods Mol Biol 209:293\u2013309","journal-title":"Methods Mol Biol"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-60761-247-6_1","volume":"573","author":"A Daugherty","year":"2009","unstructured":"Daugherty A, Lu H, Howatt DA, Rateri DL (2009) Modes of defining atherosclerosis in mouse models: relative merits and evolving standards. Methods Mol Biol 573:1\u201315","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","The Renin-Angiotensin-Aldosterone System"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7030-8_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T02:59:37Z","timestamp":1558061977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7030-8_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9781493970285","9781493970308"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7030-8_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2017]]},"assertion":[{"value":"13 May 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}